<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00765635</url>
  </required_header>
  <id_info>
    <org_study_id>CLO2008/4503</org_study_id>
    <nct_id>NCT00765635</nct_id>
  </id_info>
  <brief_title>Chlorobutanol, Potassium Carbonate, and Irrigation in Cerumen Removal</brief_title>
  <official_title>Randomized, Placebo-Controlled Evaluation of Chlorobutanol, Potassium Carbonate, and Irrigation in Cerumen Removal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Accumulation of cerumen in the external ear canal is a common problem. The presence of
      cerumen not only interferes with the clinician's view of the tympanic membrane, but may also
      result in hearing loss and vertigo, and may predispose to ear infections.

      Removal of cerumen is facilitated by the use of a variety of ceruminolytics, or wax solvents.
      The current study was designed to evaluate the ceruminolytic effects of a single, brief
      application of the two most frequently used products in the investigators area, containing
      chlorobutanol or potassium carbonate with or without irrigation in the primary care setting
      in a randomized, single-blind trial. To our knowledge, this is the first randomized study
      comparing ceruminolytics with chlorobutanol versus potassium carbonate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      INTERVENTIONS: Subjects were randomly assigned to one of three different treatments:
      Otocerum®; Taponoto ®, and a control group with sterile saline solution (NaCl 0.9%, Braun
      Medical SA, Barcelona, Spain). The test medication was instilled into an occluded ear for 15
      minutes. Following this treatment, the subject's ear was irrigated with 50 mL of water. The
      main outcome was the proportion of tympanic membranes that were completely visualized after
      cerumenolytic agents or saline, alone or with irrigation if needed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>proportion of tympanic membranes that were completely visualized after cerumenolytic agents or saline, alone or with irrigation if needed</measure>
    <time_frame>2008</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse effects</measure>
    <time_frame>2008</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Ear Infection</condition>
  <condition>Hearing Loss</condition>
  <condition>Vertigo</condition>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Taponoto ® (potassium carbonate 20 mg/1 ml, ethyl alcohol, glycerol 480, thymol 0.4; Teofarma Iberica S.A., Barcelona, Spain),</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>sterile saline solution (NaCl 0.9%, Braun Medical SA, Barcelona, Spain).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1: Chlorobutanol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ceruminolytic product, Otocerum® (Chlorobutanol 50 mg/1 ml, phenol 10 mg/1 ml, turpentine essence 0.15 ml/1 ml, ethyl alcohol; Reig Jofre laboratories, Barcelona, Spain),</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>drops intilation (Taponoto ® )</intervention_name>
    <description>four drops, unique doses</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>drops intilation (Otocerum®)</intervention_name>
    <description>four drops, unique doses</description>
    <arm_group_label>1: Chlorobutanol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>drops intilation (Placebo)</intervention_name>
    <description>Placebo</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of ear cerumen

        Exclusion Criteria:

          -  Infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Roland PS, Eaton DA, Gross RD, Wall GM, Conroy PJ, Garadi R, Lafontaine L, Potts S, Hogg G. Randomized, placebo-controlled evaluation of Cerumenex and Murine earwax removal products. Arch Otolaryngol Head Neck Surg. 2004 Oct;130(10):1175-7.</citation>
    <PMID>15492164</PMID>
  </reference>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2008</study_first_submitted>
  <study_first_submitted_qc>October 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 3, 2008</study_first_posted>
  <last_update_submitted>October 2, 2008</last_update_submitted>
  <last_update_submitted_qc>October 2, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 3, 2008</last_update_posted>
  <responsible_party>
    <name_title>Miguel Caballero / ENT specialist</name_title>
    <organization>Hospital clinic of Barcelona</organization>
  </responsible_party>
  <keyword>complete occlusion of the ear canal due to cerumen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Vertigo</mesh_term>
    <mesh_term>Otitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

